Apellis Pharmaceuticals Inc (APLS)
30.77
+3.02
(+10.88%)
USD |
NASDAQ |
Nov 22, 16:00
30.76
-0.01
(-0.03%)
After-Hours: 20:00
Apellis Pharmaceuticals Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | -0.09M |
March 31, 2024 | -0.293M |
December 31, 2023 | 0.004M |
September 30, 2023 | -0.047M |
June 30, 2023 | -0.372M |
March 31, 2023 | -0.259M |
December 31, 2022 | 124.13M |
September 30, 2022 | 124.78M |
June 30, 2022 | 82.93M |
March 31, 2022 | -271.95M |
December 31, 2021 | 84.98M |
September 30, 2021 | 179.65M |
June 30, 2021 | 129.75M |
Date | Value |
---|---|
March 31, 2021 | -146.76M |
December 31, 2020 | -0.091M |
September 30, 2020 | 198.76M |
June 30, 2020 | -287.81M |
March 31, 2020 | -227.85M |
December 31, 2019 | -0.155M |
September 30, 2019 | -0.471M |
June 30, 2019 | -0.192M |
March 31, 2019 | -0.875M |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-287.81M
Minimum
Jun 2020
198.76M
Maximum
Sep 2020
-0.5346M
Average
-0.0685M
Median
Cash from Investing (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | -16.16M |
Ionis Pharmaceuticals Inc | -340.80M |
EyePoint Pharmaceuticals Inc | 16.20M |
Cassava Sciences Inc | -0.017M |
Macrogenics Inc | 35.60M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 34.10M |
Cash from Financing (Quarterly) | 2.542M |
Free Cash Flow | -205.58M |
Free Cash Flow Per Share (Quarterly) | 0.2745 |
Free Cash Flow to Equity (Quarterly) | 39.06M |
Free Cash Flow to Firm (Quarterly) | 43.84M |
Free Cash Flow Yield | -5.43% |